Top 5 Most-Read Inflammation Articles in 2021

December 27th 2021, 1:15pm


This year's most-read inflammation articles included ones about Janus kinase inhibitors and the impact of biologics or systemic corticosteroids on severe COVID-19.

A Comparison of Administrative Claims–Based Risk Predictors for Pediatric Asthma

December 6th 2021, 2:00pm


A comparison of claims-based asthma risk predictors in a national sample of children with Medicaid determines accuracy and informs risk predictor choice.

Increased Weight Worsens Bronchial Patency in Children, Study Finds

December 1st 2021, 8:15pm


The trend was true when investigators used body mass index to classify weight, and when measures such as relative body mass index and percentage of body fat were used.

Study Finds Link Between Thalassemia, Risk of Asthma

November 26th 2021, 5:30pm


The study showed children with thalassemia had a greater risk of both atopic and non-atopic asthma.

Secondhand Smoke Leads to Respiratory Disease, Even in Adulthood

November 15th 2021, 7:48pm


As many as 4% of population-level asthma cases could be attributed to secondhand smoke, the study suggests.

Depression Doubles Health Care Costs for Patients With Respiratory Conditions

November 1st 2021, 8:45pm


The analysis found 20% of people with asthma, emphysema, or chronic bronchitis also have depression.

FDA Approves Dupilumab for Children Aged 6 to 11 With Moderate to Severe Asthma

October 20th 2021, 10:05pm


Sold under the name Dupixent, dupilumab is a biologic that inhibits interleukin (IL)-4 and IL-13, which are key drivers of the type 2 inflammation that plays a major role in asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, and eosinophilic esophagitis.

Daily Life Activity Creates Triggers in Mast Cell Disorders

October 7th 2021, 5:30pm


A recent article describes the many challenges faced by patients with mast cell disorders, which involve unpredictable, disabling symptoms that interfere with daily life activities.

Dr Michael E. Weschler: How Eosinophilic Asthma Differs From Other Eosinophilic Conditions

September 12th 2021, 2:00pm


Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, discusses the conditions that can develop as a result of abnormal eosinophilic activity.

Some JAK Inhibitors to Carry More Black Box Warnings for Cardiovascular Concerns

September 3rd 2021, 5:30pm


It is the third set of warnings for certain Janus kinase (JAK) inhibitors due to the risk of heart attack or stroke, cancer, blood clots, and death.